Within 3 Life science organizations are using technology to optimize congress insight-gathering and
drive strategy. Here are the top tips from a panel discussion with industry leaders prioritizing
a more holistic, tech-enabled view of medical congress planning to get the most meaningful,
Within 3 Leading pharmaceutical and medical device companies rely on input from key opinion leaders—KOLs—to drive their critical projects forward. Now, at the dawn of a new era of virtual work, these organizations are
freed from the timeframes and travel budgets that once constrained KOL engagement. With asynchronous
virtual engagement, experts from all over the world can gather online to participate in discussions and
provide feedback, without leaving their clinic, their family, or their day-to-day.
Within 3 Life science companies invest significant resources in annual medical conferences and other in-person and hybrid events, and it’s important to maximize this investment through adequate preparation, meaningful
participation, and actionable post-event activities.
Within 3 The way pharmaceutical and medical device teams work has changed forever, prompting some experts to predict that everything from day-to-day interactions to how clinical trials are conducted will experience
a transformation. Less business travel, more flexibility in where and when we work, and interacting with
colleagues around the world will present both opportunities and challenges to your team in the years ahead.
Within 3 Medical affairs teams rely on insights to drive strategy and enable business decisions with far-reaching
implications for their organizations, and for consumers who rely on life-changing treatments and devices.
But the processes surrounding insight-gathering are varied, complex, and time-consuming.
Within 3 Life science organizations are facing a new world and unprecedented challenges. A global pandemic
revealed vulnerabilities in processes from supply chain management to clinical trial recruitment and
execution. As the global crisis progressed, pharmaceutical and medical device teams pivoted to virtual tools
for much of their communication and collaboration.
Within 3 Life science and pharma companies have long looked to key opinion leaders (KOLs)
for insights and advice. KOLs are highly respected and highly influential within their
often large networks of peers. They are usually researchers, physicians, or other
healthcare providers (HCPs) and extremely knowledgeable about their particular
areas of expertise – it’s not surprising that the industry has recognized and embraced
their value as strategic partners.
UBC BLUE BELL, Pa. and CARY, N.C., April 27, 2021 /PRNewswire/ -- UBC, a late-stage research and patient-support services organization, and THREAD, a technology and service provide renabling DCTs, today announced UBC's selection of THREAD to leverage decentralized approaches across studies in the UBC portfolio. The fully connected offering further enables powerful decentralized approaches, rapid program start-up timelines and a more integrated offering from data acquisition through actionable insights in a single platform.
UBC The current public health crisis has accelerated collecting data in a decentralized manner. The biopharmacuetical industry had already begun to harness transformative approaches to collecting data in novel ways, including from remote sources across a wide range of settings and using diverse modalities. The pandemic has proven to be a catalyst for an even more comprehensive set of solutions to collect critical evidence beyond the walls of the traditional study setting. Regulatory agencies propelled this trend by releasing new guidances.
UBC SAN DIEGO and BLUE BELL, Pa., Feb. 3, 2022 /PRNewswire/ -- UBC, a late-stage research and patient support services organization has partnered with Seqster PDM, Inc. ("Seqster"), the leading patient-centric healthcare technology company, to provide nationwide health record interoperability with patient engagement. UBC will utilize the technology to enable clinical and observational research to transition from traditional site-based studies to decentralized clinical trials (DCTs). Seqster's turnkey white label solution facilitates the rapid move to a fully decentralized approach with automated data acquisition and abstraction.
H1 With the H1: Trial Landscape, our clients can leverage unique clinical insights for data driven decision-making, easily segmenting and analysing patient populations, to facilitate more diversity and inclusion in clinical trials.
H1 Gone are the days when Conferences & Pubs defined the KOL landscape. Social media has transformed thought leadership, and if you’re not engaging Digital Opinion Leaders, then your teams will be a step behind some of the most meaningful work.
H1 Our client, a top 25 Global Pharma company, needed to better understand the top global key opinion leaders in pulmonary disease and oncology. They also needed to identify related second and third level rising stars to ensure continued adoption and engagement at top institutions. H1 uncovered the top 50 leaders across 12 countries, identifying an additional 78 rising stars related to those top HCPs.
H1 Our client was planning a launch of a product within a new indication. To ensure they were targeting the right audience, they wanted to better understand the treatment landscape across a total of five indications. H1 delivered the top 200 HCPs in each indication and the top 200 treaters. Within 3 months the team reported an increase of 300% to their engagement metrics.
H1 has worked with the top Pharmaceuticals and Life Sciences Companies to help them better understand the HCP Universe. Specifically, H1 clients were seeking to increase MSL engagement. In reviewing the work done across those organizations, H1 uncovered an interesting trend. In companies where Medical Affairs teams engage both the top thought leaders and community treatment leaders; the MSL teams reported approximately 20% more engagements with HCPs as compared to those teams not engaging both types of thought leader. From analyzing H1 user data, we found the most impactful element for establishing community leadership to be the referral data within the HCPs profile.
LABCORP Mobile Clinical Services (MCS) uses a patient-centric approach to transforming clinical trials, allowing for a suite of clinical trial visit services to be conducted at any time, wherever the patient may be by using a centrally managed network of country coordinators and mobile service providers. Through convenient, time-saving efforts, MCS helps bring life-enhancing products to the market sooner.
LABCORP Traditionally, clinical trials follow a standardized format, whereby the participant in the trial must attend the clinical site or sites for the purposes of screening, enrollment, treatment administration and data collection. However, the rigid structure of a conventional clinical trial, has limitations for the patient, clinician and the research infrastructure, which were brought into sharp focus by the onset of the COVID-19 pandemic in early 2020
LABCORP OncologyThere is a gap between the number of patients needed to participate in new cancer trials and the number who give consent to take part. Decentralized clinical trials (DCTs) are helping to address this gap by increasing the reach of clinical studies beyond conventional research sites. DCTs provide an opportunity to remove some of the burdens associated with in-clinic visits, allowing participants to take part in trials from their own homes and/or community healthcare setting, with fewer visits to a hospital/trial site. Key to the delivery of DCTs is a suite of tools and technologies that support near real-time review of clinical data from multiple sources. This article looks at some of the technologies, tools and processes that can support more patient-centric oncology trials.
LABCORP Abstract: While adoption/acceptance/use of Mobile Clinical Services (MCS) is growing /increasing in most regions around the world, a number of Asia-Pacific countries remain hesitant to commit to this new approach to clinical trials. This case study reviews Labcorp MCS support of a global pulmonary inflammation clinical trial that was active in Australia, highlighting the benefits on a global level and the specific challenges faced in the Pacific country.
INVESTOR BRAND NETWORK LOS ANGELES, April 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting companies to the investment community through 50+ brands, today announced it will partner with Dynamic Global Events (“DGE”) as an official media partner for upcoming events in 2021. BioMedWire (“BMW”), a specialized communications platform for the life sciences sector and one of the 50+ brands part of the InvestorBrandNetwork, is also joining as an official media partner for DGE’s upcoming events.
INVESTORWIRE Lifescience and pharma professionals are invited to attend the 2nd Rx to OTC symposium being held on November 11-12, 2021. The online event is hosted by Dynamic Global Events (“DGE”), a global event company that caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
INVESTORWIRE Lifescience and healthcare professionals across all department functions, and consultants are invited to attend DGE’s Advancing Diversity, Equity & Inclusion (“DEI”) In Pharma & Healthcare Conference, streaming live online November 4-5, 2021.
INVESTORWIRE Dynamic Global Events (“DGE”) is proud to announce its 2nd Risk Evaluation and Mitigation Strategies (“REMS”) virtual summit. This two-day event, scheduled for October 11-12, 2021, will be an excellent avenue for life science professionals to develop decision making skills to adapt to anticipate FDA feedback with ease. This virtual conference is an exceptional resource for gaining new insights into adapting to risk mitigation strategies regarding submissions and modifications.
INVESTORWIRE Pharma professionals, healthcare providers, influencers, and healthcare-related industries are invited to attend DGE’s 7th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare being held on September 22-24, 2021, as a live online event. The event is organized by Dynamic Global Events (“DGE”), a Life Science leader in hosting B2B events. This global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
INVESTORWIRE Dynamic Global Events (“DGE”) invites biopharma and medical device industry professionals to join them online September 16-17, 2021, for the 2nd Clinical Trial Agreements Conference. DGE’s first event was held online earlier this year and was focused greatly on the COVID-19 pandemic, the confidentiality of subject data, and the increased use of telemedicine, among other topics. The first event helped industry professionals determine what needed to be considered before entering into a clinical trial agreement.
INVESTORWIRE Professionals and executives in pharmaceutical, biotech, and medical device companies are invited to attend DGE’s 2nd Human Factors Engineering & Usability Studies Congress being held on September 9-10, 2021. The leading industry conference will offer an educational experience on designing and testing safe and intuitive medical products for all user groups while adapting to regulatory compliance and the unpredictable post-COVID pandemic impact.
INVESTORWIRE Pharmaceutical, biotech, and medical device professionals/employees are invited to attend DGE’s Pharma Employee Engagement & Experience Summit on August 30-31, 2021. The Summit will concentrate on core areas to cultivate positives, maintain trust, and prioritize equity to achieve a safe, productive workforce experience. The conference will address the most vital employee engagement concerns, guided by valuable inputs from pharma leaders and thinkers who will share their insights and opinions in the 2-day event.
INVESTORWIRE Medical professionals are invited to attend DGE’s Blockchain Pharma & Life Sciences Summit on August 23-24, 2021 to learn successful strategies of successfully using the decentralized technology to boost trust and improve transparency throughout the life science ecosystem including regulators, contract manufacturers, physicians, and patients.
INVESTORWIRE Clinical researchers, medical managers, pharma companies, and life science professionals are invited to attend the 2nd Electronic Trial Master File (“eTMF”) Forum on August 16-17th, 2021. This 2-day event will offer a leading stage to learn the skills of integrated TMF technology for successful clinical research. Attendees will understand the intricacies of identifying the challenges and risks posed during clinical research. They will learn to identify how to protect the data gathered during the research trials, meeting regulatory requirements, preparing for audits, getting ready for inspections, and lucrative techniques for monitoring and filing correspondence.
INVESTORWIRE On July 28-30, 2021, medical officers and healthcare professionals are invited to attend DGE’s 4th Digital & Innovation For Medical Affairs Summit to learn and upskill with the progressive technologies and novel policies of the digital era. This online live streaming event is organized by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
INVESTORWIRE Chief Patient officers and leaders of engagement, advocacy, communications and support services, are invited to attend the inaugural Chief Patient Officer Summit on July 22-23, 2021, organized by DGE. This online live streaming event is driven to focus on opportunities and challenges faced by Chief Patient officers and executives while offering a seamless patient experience.
BIOMEDWIRE Biopharma medical writing and communications professionals are invited are invited to attend DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences live streaming on June 29-30, 2021. The event will offer useful tips and guide medical professionals to learn innovative skills for filtering technical information that is effectively communicated for engagement.
INVESTOR BRAND NETWORK Medical Science Liaisons (MSLs), along with pharma companies and other life science professionals, are invited to attend DGE’S inaugural Next-Gen MSL Excellence Symposium being held on June 23-24, 2021. This symposium is the only virtual industry event to focus on the work challenges faced by MSLs, to emphasize the importance of their role in drug and device development and adapting to new technologies in the Post-COVID scenario.
INVESTOR BRAND NETWORK The COVID-19 impact has brought a paradigm shift in the responsibilities of medical professionals. This ‘new normal’ requires updates and revised training of medical professionals to adapt to the new hybrid work environment.
INVESTOR BRAND NETWORK As marketing gets personalized and consumers expect to be reached on their channel of preference, pharma companies are spending significantly on marketing and sales. On June 10-11, 2021, life science professionals are invited to attend DGE’s Omnichannel Marketing Strategy Symposium to learn skills and techniques for developing a personalized marketing strategy for consumers.
INVESTOR BRAND NETWORK The worldwide impact of COVID-19 has shifted the landscape of clinical trials forever. On June 3-4 2021, biopharmaceutical and medical device companies are invited to attend the Live Streaming of the Risk-Based Quality Management Summit. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events.
INVESTOR BRAND NETWORK As the impact of COVID-19 is felt stronger than ever, the need for virtual clinical trials is now more essential, than ever. In wake of the rising need for virtual clinical trials. The 4th Virtual Clinical Trials conference will be live-streamed on 17 18TH May 2020. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events.
INVESTORWIRE Described as relatable, dynamic, passionate, and inspirational, Colleen Hauk – the event’s speaker – has made a name for herself as a seasoned trainer, speaker, and co-author of two books. Colleen always seeks to empower her audiences and clients to expand their minds beyond what is expected so that they can strike a balance between leadership and their personal lives. She has delivered trainings and keynotes to various renowned organizations, including Panasonic, Dell, Coldwell Banker, US Foods, and more (https://ibn.fm/qTNlQ).
INVESTOR BRAND NETWORK The COVID-19 fear increases as the pandemic spreads its way into the second year of impacting people’s day-to-day affairs, not only in the United States but throughout the world, the role of KOLs becomes even more important role in each stage of the drug life cycle. The KOL & Thought Leader Engagement Summit will commence as a live streaming event on 28th-29th April.
BIOMEDWIRE Companies view mergers and acquisitions (“M&A”) as opportunities to broaden their portfolio, expand to international markets and increase leverage and scale. In the MedTech industry, in particular, companies look at M&A as an opportunity to drive positive financial growth and enhance therapeutic solutions (https://ibn.fm/yqmb6), as well as to address industry changes such as those brought by newly introduced regulations, slowed health care spending, negative pricing trends or, more recently, the pandemic.
MCDERMOTT WILL & EMERY The US Food and Drug Administration (FDA) became a central focus of US and global attention in 2020, since the agency regulates many of the therapies, treatments and interventions necessary to mitigate and combat the COVID-19 pandemic. The agency faced many challenges in light of the inevitable politicization of a public health emergency, exercising rarely used authorities to facilitate an expedient response to the pandemic in addition to pushing forward its traditional regulatory agenda.
MONOCL External experts are sought-after advisors for life science companies, where they inform critical decisions along the entire product lifecycle of a drug. These experts use the knowledge and experience they acquired over the course of their careers to help companies address challenges like identifying unmet medical needs, clinical trial design, stratification of patient populations, label extensions, product positioning, regulatory challenges and many others. They can also serve as the scientific face of the organization, e.g. by discussing trial results during conferences and/or co-authoring scientific publications.
San Francisco, CA (December 9, 2020) - Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced that Clovis Oncology has selected Alucio’s Beacon as its scientific exchange platform. Beginning in January 2021, Beacon will be used by Clovis medical affairs to manage medical and scientific content for field use, and enable their medical science liaisons (MSLs) to more effectively engage with healthcare professionals (HCPs) both in the US and Europe.
San Francisco, CA (November 10, 2020) -Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced the release of new features for Beacon’s mobile phone users. These enhancements optimize the user experience for meeting attendees participating in virtual scientific exchanges on their smartphones.
San Francisco, CA (September 24, 2020) - Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, announced today that it has joined The Board Challenge (www.theboardchallenge.org) initiative created to improve the representation of Black directors in corporate US boardrooms. Companies taking The Board Challenge pledge commit to adding a Black director to their board within the next year.
Many of us spend hours in back-to-back virtual meetings these days. While these video engagements are convenient and relatively simple to set up, they also bring a number of challenges for presenters – including for those delivering scientific content and engaging with healthcare professionals (HCPs).